Oct 20, 2020 | Brian Fargus, Caroline Fraker, MedBen employees, MedBen Rx, Pharmacogenomics, Specialty Drugs
MedBen Vice Presidents Caroline Fraker and Brian Fargus were among the featured speakers at the Sherrill-Morgan 7th Annual Healthcare Innovation Conference on Thursday, October 1. In her presentation, Senior Vice President Fraker discussed the potential problems of...
Sep 5, 2020 | Prescription drugs, Specialty Drugs
Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at...
Feb 28, 2019 | Government, Legislation, MedBen Rx, Rx Costs, Rx Spending, Specialty Drugs
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
